Tianyu’s first-author paper titled “Evaluation of the Potential of 2-Amino-3-(1,7-dicarba-closo-dodecaboranyl-1-thio)propanoic Acid as a Boron Neutron Capture Therapy Agent” was accepted by ACS Omega.
Tianyu’s first-author paper titled “Evaluation of the Potential of 2-Amino-3-(1,7-dicarba-closo-dodecaboranyl-1-thio)propanoic Acid as a Boron Neutron Capture Therapy Agent” was accepted by ACS Omega.
